These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32923401)

  • 1. Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer.
    Xu N; Ke ZB; Chen YH; Wu YP; Chen SH; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY
    Front Oncol; 2020; 10():1547. PubMed ID: 32923401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patients.
    Song G; Ruan M; Wang H; Lin Z; Wang X; Li X; Li P; Wang Y; Zhou B; Hu X; Liu H; Wang H; Guo Y
    Transl Androl Urol; 2020 Apr; 9(2):437-444. PubMed ID: 32420149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive model containing PI-RADS v2 score for postoperative seminal vesicle invasion among prostate cancer patients.
    Wang H; Ruan M; Wang H; Li X; Hu X; Liu H; Zhou B; Song G
    Transl Androl Urol; 2021 Feb; 10(2):584-593. PubMed ID: 33718061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the prostate imaging reporting and data system version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment.
    Liu C; Liu SL; Wang ZX; Yu K; Feng CX; Ke Z; Wang L; Zeng XY
    Asian J Androl; 2018; 20(5):459-464. PubMed ID: 29667616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
    Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of PI-RADS v2 scores combined with prostate specific antigen in diagnosis of peripheral zone prostate cancer: a logistic regression analysis].
    Lei LZ; Xu YK; Hou MR; He MQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Aug; 37(8):1092-1097. PubMed ID: 28801291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    Yim JH; Kim CK; Kim JH
    J Magn Reson Imaging; 2018 Apr; 47(4):1072-1079. PubMed ID: 28901655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prediction value of PI-RADS v2 score in high-grade Prostate Cancer: a multicenter retrospective study.
    Chen S; Yang Y; Peng T; Yu X; Deng H; Guo Z
    Int J Med Sci; 2020; 17(10):1366-1374. PubMed ID: 32624693
    [No Abstract]   [Full Text] [Related]  

  • 9. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
    Zhai L; Fan Y; Sun S; Wang H; Meng Y; Hu S; Wang X; Yu W; Jin J
    Scand J Urol; 2018; 52(5-6):333-339. PubMed ID: 30895901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation analysis between prostate imaging report and data system score and pathological results of prostate cancer].
    Zhu LY; Ding XF; Huang TB; Luan Y; Guo CH; Xu YZ; Wang F
    Zhonghua Yi Xue Za Zhi; 2020 Sep; 100(34):2663-2668. PubMed ID: 32921014
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing a prediction model for prostate cancer bone metastasis.
    Chen S; Wang L; Qian K; Jiang W; Deng H; Zhou Q; Wang G; Liu X; Wu CL; Xiao Y; Wang X
    Int J Biol Sci; 2019; 15(1):208-220. PubMed ID: 30662360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml?
    Xu N; Wu YP; Chen DN; Ke ZB; Cai H; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY
    J Cancer Res Clin Oncol; 2018 May; 144(5):987-995. PubMed ID: 29504080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?
    Zhang Y; Zeng N; Zhang F; Huang Y; Tian Y
    Int J Clin Oncol; 2020 Jan; 25(1):175-186. PubMed ID: 31473884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI-RADS v2.1 evaluation of prostate "nodule in nodule" variants: clinical, imaging, and pathological features.
    Sun M; Xu L; Zhang X; Cao L; Chen W; Liu K; Wu H; Xie D
    Insights Imaging; 2024 Mar; 15(1):79. PubMed ID: 38499703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer.
    Cao Y; Cao M; Chen Y; Yu W; Fan Y; Liu Q; Gao G; Zhao Z; Wang X; Jin J
    Oncotarget; 2017 Jul; 8(27):44040-44049. PubMed ID: 28476042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of relationships between the final Gleason score, PI-RADS v2 score, ADC value, PSA level, and tumor diameter in patients that underwent radical prostatectomy due to prostate cancer.
    Gündoğdu E; Emekli E; Kebapçı M
    Radiol Med; 2020 Sep; 125(9):827-837. PubMed ID: 32266690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI-RADS v2 and ADC values: is there room for improvement?
    Jordan EJ; Fiske C; Zagoria R; Westphalen AC
    Abdom Radiol (NY); 2018 Nov; 43(11):3109-3116. PubMed ID: 29550953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients.
    Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G
    Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.